Stockreport

Sanofi bets up to $1.53B to license blood cancer drug from Sino Biopharma unit [Seeking Alpha]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF that one of its subsidiaries has reached an agreement with Sanofi ( SNY ) to out-license a blood cancer drug named rovadicitinib to the French drugmaker in a deal [Read more]